More diuretics = more diuresis

The ADVOR trial (adding acetazolamide in acute heart failure) is covered by #TenTweetNephJC

Welcome to #TenTweetNephJC

✳️ 10 tweet #NephJC catch-up ✳️

Did you ever think of using acetazolamide for acute congestive heart failure?

Read on to see whether we should or we should not! pic.twitter.com/e6XHi1JouG

— Nephrology Jrnl Club (@NephJC) September 26, 2022

The ANCA PLEX commentary on Kidney Medicine

The commentary on the BMJ meta-analysis on PLEX in ANCA vascuitis is now online on Kidney Medicine. Nice work by Anoushka Krishnan, Cristina Popa and Priyadarshini John. Read the paper here

Is piperacillin-tazobactam nephrotoxic?

The debate continues, but this time with cystatin-C measurements. Read the #TenTweetNephJC summary here!

Welcome to #TenTweetNephJC tweetorial

✳️ 10 tweets to catch-up with #NephJC ✳️

Have you ever prescribed piperacillin-tazobactam? Or avoided it due to fear of causing AKI?

Read on to learn more about the ‘nephrotoxin’ versus ‘pseudonephrotoxin’ debate pic.twitter.com/ZKX1ElhZds

— Nephrology Jrnl Club (@NephJC) September 13, 2022

ADVOR TRIAL - The Visual Abstract

Does acetazolamide help decongest in acute decompensated heart failure with volume overload? NSMC Intern Dr Api Chewcharat explains it with a beautiful visual abstract

View fullsize

Vancomycin/Pip-Taz associated AKI - The Visual Abstract

Is Vancomycin/Piperacillin-tazobactam combination associated with higher rates of AKI?

Adeyemo Abiodun explains it beautifully with his visual abstract

View fullsize

And luckily this chat has another wonderful visual abstract by PS Vali.

View fullsize